Literature DB >> 22211715

Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis.

Maria João Rocha1, Susana Ferreira, La Salete Martins, Manuela Almeida, Leonídeo Dias, Sofia Pedroso, António Castro Henriques, Rui Almeida, António Cabrita.   

Abstract

Renal replacement therapies (RRT) for patients with end-stage renal failure represent a high burden on European countries' healthcare budget. Our purpose was to report and compare the costs of RRT by hemodialysis (HD) or peritoneal dialysis (PD) and renal transplantation (RT) after introduction of a bundled payment system of dialysis. We analyzed average annual cost of RT in a public national health system hospital - surgical/anesthesiologist team and material, induction and maintenance immunosuppression therapy, hospital stay, diagnostic examinations (DE), and post-transplant office visits (including DE). Incentives paid to hospitals performing RT were included. Annual cost of HD or PD was estimated by bundled payment established in a recently revised law - 537.25 €/wk. Total first year cost or RT is 61 658.14 € and from the second year forth 543.86 €/month. Dialysis costs 28 033.71 €/yr. Break-even point for cost is at 32 months, and from there on, RT is less expensive. Strategies aimed at increasing RT are needed as it confers better survival than RRT by dialysis with lower costs to Portuguese health system.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 22211715     DOI: 10.1111/j.1399-0012.2011.01571.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  5 in total

Review 1.  Estimating glomerular filtration rate in kidney transplantation: Still searching for the best marker.

Authors:  Josefina Santos; La Salete Martins
Journal:  World J Nephrol       Date:  2015-07-06

2.  Cost of Stem Cell-Based Tissue-Engineered Airway Transplants in the United Kingdom: Case Series.

Authors:  Emily J Culme-Seymour; Katrina Mason; Laura Vallejo-Torres; Carla Carvalho; Leanne Partington; Claire Crowley; Nick J Hamilton; Ed C Toll; Colin R Butler; Martin J Elliott; Martin A Birchall; Mark W Lowdell; Chris Mason
Journal:  Tissue Eng Part A       Date:  2015-12-24       Impact factor: 3.845

3.  The patient-breast cancer care pathway: how could it be optimized?

Authors:  Sandrine Baffert; Huong Ly Hoang; Anne Brédart; Bernard Asselain; Séverine Alran; Hélène Berseneff; Cyrille Huchon; Caroline Trichot; Aline Combes; Karine Alves; Martin Koskas; Thuy Nguyen; Aurélie Roulot; Roman Rouzier; Delphine Héquet
Journal:  BMC Cancer       Date:  2015-05-12       Impact factor: 4.430

Review 4.  How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings?

Authors:  Yot Teerawattananon; Alia Luz; Songyot Pilasant; Suteenoot Tangsathitkulchai; Sarocha Chootipongchaivat; Nattha Tritasavit; Inthira Yamabhai; Sripen Tantivess
Journal:  Health Res Policy Syst       Date:  2016-03-18

5.  Costs of Long-Term Post-Transplantation Care in Kidney Transplant Recipients.

Authors:  Anna Łabuś; Mariusz Niemczyk; Łukasz Czyżewski; Magda Fliszkiewicz; Andrzej Kulesza; Krzysztof Mucha; Leszek Pączek
Journal:  Ann Transplant       Date:  2019-05-07       Impact factor: 1.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.